TERN
Terns Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$46.52
+2.28 ▲ +5.15%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$47.50
+0.98 ▲ +2.11%
| Index | RUT | P/E | - | EPS (ttm) | -1.03 | Insider Own | 9.95% | Shs Outstand | 0.11B | Perf Week | 8.64% |
| Market Cap | 4.95B | Forward P/E | - | EPS next Y | -10.88% | Insider Trans | -1.68% | Shs Float | 0.10B | Perf Month | 20.39% |
| Enterprise Value | 4.65B | PEG | - | EPS next Q | -0.29 | Inst Own | 108.87% | Short Float | 17.35% | Perf Quarter | 4.28% |
| Income | -0.09B | P/S | - | EPS this Y | 3.71% | Inst Trans | 44.01% | Short Ratio | 7.45 | Perf Half Y | 525.27% |
| Sales | 0.00B | P/B | 14.33 | EPS next 5Y | -8.32% | ROA | -27.78% | Short Interest | 16.62M | Perf YTD | 15.15% |
| Book/sh | 3.25 | P/C | 16.73 | EPS past 3/5Y | 17.43% 16.38% | ROE | -29.12% | 52W High | -3.61% ($48.26) | Perf Year | 1248.41% |
| Cash/sh | 2.78 | P/FCF | - | Sales past 3/5Y | - | ROIC | -33.18% | 52W Low | 2394.37% ($1.87) | Perf 3Y | 396.48% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 12.45% | Gross Margin | - | Volatility(W/M) | 6.17% 5.83% | Perf 5Y | 79.54% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 2.57 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 19.52 | EPS Q/Q | 4.75% | Profit Margin | - | RSI (14) | 67.8 | Recom | 1.09 |
| Dividend Gr. 3/5Y | - | Current Ratio | 19.52 | Sales Q/Q | - | SMA20 | 10.74% ($42.01) | Beta | -0.28 | Target Price | $58.11 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | 19.65% ($38.88) | Rel Volume | 1.9 | Prev Close | $44.24 |
| Employees | 59 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 8.26% - | SMA200 | 140.01% ($19.38) | Avg Volume(3M) | 2.23M | Price | $46.52 |
| IPO | 2021/2/5 | Option/Short | Yes/Yes | Trades | 29801 | Volume | 4,243,995 | Change | 5.15% |
뉴스 로딩 중...